ALT
NASDAQStockAltimmune, Inc.
$3.52-0.08 (-2.34%)
52-Week Range
$3.38
$7.71
Key Stats
Market Cap
310.3M
P/E Ratio
—
Dividend Yield
—
Beta
0.17
Volume
2.1M
Avg Volume
3.5M
Performance
1M
-21.23%
3M
-31.82%
6M
+0.28%
YTD
+2.56%
1Y
-39.19%
3Y
-67.06%
5Y
-79.70%
Price Chart
ETF Exposure
ALT is held by 66 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| BBC | Virtus Biotech Clinical Trials ETF | 0.53% |
| QQQS | Invesco NASDAQ Future Gen 200 ETF | 0.35% |
| XCMC.L | Xtrackers Bloomberg Commodity Swap UCITS ETF 1C | 0.26% |
| SBIO | ALPS Medical Breakthroughs ETF | 0.25% |
| CURE.AX | Global X - S&P Biotech ETF | 0.15% |
| XBI | State Street SPDR S&P Biotech ETF | 0.15% |
| IWC | iShares Micro-Cap ETF | 0.07% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.05% |
| IBB | iShares Biotechnology ETF | 0.04% |
| PWS | Pacer WealthShield ETF | 0.03% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.03% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.03% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.03% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.03% |
| IWO | iShares Russell 2000 Growth ETF | 0.02% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.02% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.02% |
| VTWO | Vanguard Russell 2000 ETF | 0.02% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.01% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.01% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.01% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.01% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.01% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.01% |
| DFAS | Dimensional - US Small Cap ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| AVSU | Avantis Responsible U.S. Equity ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| SILX | ETFMG Prime 2x Daily Junior Silver Miners ETF | 0.00% |
| VALT | ETFMG Sit Ultra Short ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
Page 1 of 2Next
About ALT ETF Exposure
Altimmune, Inc. (ALT) is held by 66 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 310.3M, ALT is a widely held institutional stock. The stock currently trades at $3.52. Investors can gain exposure to ALT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ALT, sorted by portfolio weight.